Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92,744Revenue (TTM) $M14,967Net Margin (%)100Altman Z-Score--
Enterprise Value $M112,288EPS (TTM) $37.4Operating Margin %-12.1Piotroski F-Score--
P/E(ttm)6.6Beneish M-Score--Pre-tax Margin (%)-18.8Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales6.45-y EBITDA Growth Rate %4.7Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow78.2y-y EBITDA Growth Rate %70.9ROA % (ttm)10.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)18.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M375ROIC % (ttm)-0.5Gross Margin Increase y-yN

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AGN is held by these investors:



AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Basgoz NesliDirector 2016-12-08Sell500$188.7231.07view
SAUNDERS BRENT LCEO and President 2016-11-21Buy5,250$189.1330.78view
Hilado Maria TeresaCFO 2016-11-11Buy1,422$210.6417.43view
Basgoz NesliDirector 2016-08-05Sell758$253.02-2.24view
Hilado Maria TeresaCFO 2016-06-02Buy661$241.572.39view
Basgoz NesliDirector 2016-05-11Sell459$225.19.88view
Basgoz NesliDirector 2015-12-07Sell2,300$312.96-20.96view
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.42-16.83view
SAUNDERS BRENT LCEO and President 2015-08-21Buy1,000$301.94-18.08view
Basgoz NesliDirector 2015-06-09Sell2,200$297.89-16.97view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
Where Seth Klarman Sees Value in Today’s Market Feb 15 2017 
Daniel Loeb Drops Pharma, Picks Up Rate-Sensitive Financials Feb 13 2017 
How BioVie, Conatus and PhaseRX Tackle Liver Diseases Feb 08 2017 
Daniel Loeb's Third Point Hedge Fund 4th Quarter Commentary Feb 02 2017 
Weitz Funds Comments on Allergan Jan 26 2017 
Teva Is a Hold Nov 30 2016 
Weekly CEO Buys Highlight Nov 29 2016 
Weekly Top Insider Buys Highlight for Week of Nov. 18 Nov 19 2016 
John Griffin Expands Portfolio in 3rd Quarter Nov 16 2016 

More From Other Websites
Riddle Me This; Bendable Market: Best of Kass Feb 17 2017
Stull, Stull & Brody is Investigating Claims on Behalf of Allergan’s (NYSE:AGN) 401(k) Plan Feb 17 2017
Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ Feb 17 2017
Stress boom to boost drug sales? Feb 16 2017
David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017
5 Ways Allergan Can Keep Up Momentum Feb 15 2017
Tepper's Appaloosa Fund Continues Bet on Drug Companies in Q4 2016 Feb 15 2017
Tepper's Appaloosa triples stake in Allergan Feb 15 2017
Billionaire Dan Loeb’s Biggest Q4 Moves Include Bank-Buying Spree, Selling Allergan (AGN) Feb 15 2017
Medicines360 And Allergan Announce Partnership With Health Centers To Help Address Unintended... Feb 15 2017
What the Smart Money's buying Feb 14 2017
David Tepper Increases Wagers on Drug Companies Feb 14 2017
Bets on financials, pharma power U.S. hedge funds' strong start to year Feb 14 2017
David Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks Feb 14 2017
Appaloosa Management snaps up Allergan shares in 4th quarter Feb 14 2017
Hologic Follows Allergan, Buying Body-Sculptor Cynosure For $1.65 Bil Feb 14 2017
ETFs with exposure to Allergan Plc : February 14, 2017 Feb 14 2017
Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan Feb 14 2017
Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit Feb 14 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)